OCX 2.74 (+3.4%)
US68235C1071BiotechnologyBiotechnology

OncoCyte (OCX) Stock Highlights

2.74 | +3.4%
2024-06-03 04:41:42
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests.

Statistics

Range Today
2.71 2.95
Volume Today 40.5K
Range 1 Year
2.08 4.86
Volume 1 Year 7.01M
Range 3 Year
2.08 125
Volume 3 Year 18.73M
Range 10 Year
2.08 204.8
Volume 10 Year 44.83M

Highlights

Market Capitalization 36.62M (micro)
Floating Shares 5.74M
Current Price 2.74
Price To Earnings -0.52
Price To Revenue 27.86
Price To Book 1.96
Earnings Per Share -5.32
Payout Ratio 0%

Performance

Latest +3.4%
1 Month +7.03%
3 Months -8.97%
6 Months -25.95%
1 Year -38.29%
3 Years -96.94%
5 Years -96.63%
10 Years -95.58%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.